Literature DB >> 18336590

Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

A Reschner1, P Hubert, P Delvenne, J Boniver, N Jacobs.   

Abstract

Dendritic cells (DC) are specialized in the presentation of antigens and the initiation of specific immune responses. They have been involved recently in supporting innate immunity by interacting with various innate lymphocytes, such as natural killer (NK), NK T or T cell receptor (TCR)-gammadelta cells. The functional links between innate lymphocytes and DC have been investigated widely and different studies demonstrated that reciprocal activations follow on from NK/DC interactions. The cross-talk between innate cells and DC which leads to innate lymphocyte activation and DC maturation was found to be multi-directional, involving not only cell-cell contacts but also soluble factors. The final outcome of these cellular interactions may have a dramatic impact on the quality and strength of the down-stream immune responses, mainly in the context of early responses to tumour cells and infectious agents. Interestingly, DC, NK and TCR-gammadelta cells also share similar functions, such as antigen uptake and presentation, as well as cytotoxic and tumoricidal activity. In addition, NK and NK T cells have the ability to kill DC. This review will focus upon the different aspects of the cross-talk between DC and innate lymphocytes and its key role in all the steps of the immune response. These cellular interactions may be particularly critical in situations where immune surveillance requires efficient early innate responses.

Entities:  

Mesh:

Year:  2008        PMID: 18336590      PMCID: PMC2384094          DOI: 10.1111/j.1365-2249.2008.03624.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  99 in total

1.  Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses.

Authors:  Ralph Mocikat; Heidi Braumüller; Alain Gumy; Oliver Egeter; Heike Ziegler; Uwe Reusch; Anja Bubeck; Jacques Louis; Reinhard Mailhammer; Gert Riethmüller; Ulrich Koszinowski; Martin Röcken
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

2.  NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Authors:  Ian F Hermans; Jonathan D Silk; Uzi Gileadi; Mariolina Salio; Bini Mathew; Gerd Ritter; Richard Schmidt; Adrian L Harris; Lloyd Old; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

3.  Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.

Authors:  Manfred Brigl; Lynn Bry; Sally C Kent; Jenny E Gumperz; Michael B Brenner
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

4.  Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.

Authors:  Gabriella Pietra; Chiara Romagnani; Paola Mazzarino; Enrico Millo; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

5.  Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

Authors:  Diego Tosi; Roberta Valenti; Agata Cova; Gloria Sovena; Veronica Huber; Lorenzo Pilla; Flavio Arienti; Filippo Belardelli; Giorgio Parmiani; Licia Rivoltini
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy.

Authors:  Yoshihiro Hayakawa; Valentina Screpanti; Hideo Yagita; Alf Grandien; Hans-Gustaf Ljunggren; Mark J Smyth; Benedict J Chambers
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

7.  Flexible migration program regulates gamma delta T-cell involvement in humoral immunity.

Authors:  Marlene Brandes; Katharina Willimann; Alois B Lang; Ki-Hoan Nam; Chenggang Jin; Michael B Brenner; Craig T Morita; Bernhard Moser
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

8.  Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells.

Authors:  Nathalie Vanderheyde; Peter Vandenabeele; Michel Goldman; Fabienne Willems
Journal:  Immunol Lett       Date:  2004-02-15       Impact factor: 3.685

9.  HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation.

Authors:  Angela Granelli-Piperno; Angelika Golebiowska; Christine Trumpfheller; Frederick P Siegal; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

10.  The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.

Authors:  Shin-Ichiro Fujii; Kang Liu; Caroline Smith; Anthony J Bonito; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-14       Impact factor: 14.307

View more
  24 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Activation of cord blood myeloid dendritic cells by Trypanosoma cruzi and parasite-specific antibodies, proliferation of CD8+ T cells, and production of IFN-γ.

Authors:  Patricia Rodriguez; Yves Carlier; Carine Truyens
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

3.  Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies.

Authors:  Hannah Frizzell; Jaehyung Park; Natacha Comandante Lou; Kim A Woodrow
Journal:  Cell Immunol       Date:  2016-10-13       Impact factor: 4.868

4.  In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers.

Authors:  C Ponte; L Peres; S Marinho; J Lima; M Siqueira; T Pedro; P De Luca; C Cascabulho; L R Castello-Branco; P R Z Antas
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

Review 6.  Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

Authors:  Christiane Geiger; Elfriede Nössner; Bernhard Frankenberger; Christine S Falk; Heike Pohla; Dolores J Schendel
Journal:  J Mol Med (Berl)       Date:  2009-03-07       Impact factor: 4.599

Review 7.  The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.

Authors:  Robin J Prestwich; Fiona Errington; Rosa M Diaz; Hardev S Pandha; Kevin J Harrington; Alan A Melcher; Richard G Vile
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

8.  Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus.

Authors:  Felix N Toka; Charles Nfon; Harry Dawson; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2009-10-14

9.  Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation.

Authors:  Nicolas Charles; Wendy T Watford; Haydeé L Ramos; Lars Hellman; Hans C Oettgen; Gregorio Gomez; John J Ryan; John J O'Shea; Juan Rivera
Journal:  Immunity       Date:  2009-04-09       Impact factor: 31.745

10.  Potential therapy of Fc-antigen combination-encoding DNA vaccination in mouse allergic airway inflammation.

Authors:  Y Wang; G Qian; G Wang; X Cheng; C Bai; X Wang
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.